Fundraise / allotmentMajor development· Adverse for the businessFiled on BSE ·

Neogen Chemicals reports June 2026 quarter results; board OKs ₹600 crore raise plan

Neogen Chemicals · Chemicals & Petrochemicals

Arthneeti Research DeskPublished 1 min read
₹600 CrFundraise / allotment

Key highlights

  • Consolidated net profit was Rs. 17.11 crore for the quarter ended June 30, 2026 against Rs. 10.26 crore a year earlier; revenue was Rs. 250.29 crore against Rs. 186.73 crore.
  • Board gave in-principle approval to raise funds up to Rs. 600 crores, including by QIP, subject to approval of members and other regulatory approvals.
  • Crisil downgraded ratings on July 17, 2026 to Crisil A2 from Crisil A1 and Crisil A-/Negative from Crisil A/Negative; coupon on Rs. 200 crore NCDs rose from 10.50% to 11.00%.

Why it's rated major development: credit rating downgrade is always high

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Outcome Of Board Meeting

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Neogen Chemicals

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.